F16 is a small, cationic, lipophilic molecule which binds preferentially to mitochondrial membranes and disrupts their function.1 F16 was discovered in high throughput screens for tumor inhibitors, where it was found to induce apoptosis in HER-1/EGFR-expressing breast carcinoma cell lines. In addition to being a potential antitumor agent, F16 is an easily visualized fluorescent molecule which can also be used to visualize mitochondria under confocal microscopy. The mechanism of apoptosis induction by F16 is believed to be through disruption of the mitochondrial transmembrane potential.1
1
Fantin, V.R., Berardi, M.J., Scorrano, L., et al. A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth. Cancer Cell229-42(2002).
Room temperature
in continental US; may vary elsewhere
SMILES
Copy SMILES to clipboard
C[n]1ccc(cc1)\C=C/c1c[nH]c2ccccc12
Background Reading
Fantin, V.R., Berardi, M.J., Scorrano, L., et al. A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth. Cancer Cell229-42(2002).
F16 is available in the following screening
library: